Trials / Completed
CompletedNCT02926807
Trial on Vascular Inflammation in Atopic Dermatitis
Vascular Inflammation and Coronary Atherosclerosis Risks in Subjects With Atopic Dermatitis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 57 (actual)
- Sponsor
- Innovaderm Research Inc. · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
A total of 30 subjects with moderate to severe atopic dermatitis. Thirty subjects without AD matched for sex, age and coronary artery disease risk factor with the AD subjects will also be included. All subjects will undergo the following imaging procedures: a 18FDG-PET to quantify vascular inflammation in the ascending aorta and carotids and a MDCT to calculate the Agatston score. Skin and blood biomarkers will also be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | FDG-PET Scan | a 18FDG-PET to quantify vascular inflammation |
| OTHER | MDCT | a MDCT to calculate the Agatston score |
| OTHER | biopsy and blood collection | biopsy and blood collection to assess biomarkers |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2018-11-01
- Completion
- 2018-11-01
- First posted
- 2016-10-06
- Last updated
- 2018-12-19
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02926807. Inclusion in this directory is not an endorsement.